Spatial transcriptome sequence data from HER2-positive human breast tumors (n=8, with 3 or 6 sections from each)

• DS DUO:0000007 (version: 2019-01-07)disease specific researchThis data use permission indicates that use is allowed provided it is related to the specified disease.ModifiersMONDO:0007254
• IRB DUO:0000021 (version: 2019-01-07)ethics approval requiredThis data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
• IS DUO:0000028 (version: 2019-01-07)institution specific restrictionThis data use modifier indicates that use is limited to use within an approved institution.

Policy for data accessibility of the raw data in the study

Data Use Limitations: (including applicable Data Use Ontology terms) • Use of the Data is limited to research on breast cancer (Mondo Disease Ontology: MONDO:0007254) for health/medical/biomedical purposes (DS, DUO:0000007). • Data Recipient must provide documentation of approval by a local Ethical Review Board or equivalent (IRB, DUO:0000021). • Use of the Data is limited to not-for-profit organizations and not-for-profit use, non-commercial use (NPUNCU, DUO:0000018). • The Data must only be used for purposes within the limits dictated by the informed consent of the Data Subjects. • The Data must not be used to identify germline variants associated with a high risk of developing cancer (e.g. variants in BRCA1, BRCA2, TP53 and similar). • Data Recipient is expected to report to Provider any Incidental Findings that could potentially affect the health of a Data Subject, living relatives of the Data Subject, or their offspring. This includes information that reveal likely life-threatening conditions, a significant risk of likely life-threatening conditions, grave conditions that can be avoided or ameliorated, a significant risk of grave conditions that can be avoided or ameliorated and genetic information that can be used in reproductive decision-making to avoid significant risk for offspring of a condition likely to be life-threatening or grave or to ameliorate a condition likely to be life-threatening or grave. Spatial transcriptome sequence data from HER2-positive human breast tumors (n=8)